Bone health and treatments
Bone health and treatments is a research topic within Oncology. Science Explorer counts 43k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the use of bisphosphonates in the treatment of bone metastases and associated complications, particularly osteonecrosis of the jaw. It explores the mechanisms of action, clinical features, and therapeutic opportunities for bisphosphonates in cancer treatment, with a specific emphasis on prostate and breast cancer. The papers also discuss the role of bisphosphonates in maintaining bone health and preventing skeletal complications in cancer patients.
- Bisphosphonates
- Osteonecrosis of the Jaw
- Bone Metastasis
- Cancer Treatment
- Skeletal Complications
- Mechanism of Action
- Metastatic Bone Disease
- Clinical Practice Guidelines
- Prostate Cancer
- Breast Cancer
- Research works
- 43k fractional, since 1950
- In the world top 10%
- 4.3k per year above
- Top-10% rate
- 10.0% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- -7% the tick is no change
- Largest producer
United States
27% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Bone health and treatments research?
By volume, the United States and China publish the most (1.1k and 938 works in 2022-now).
By volume, 2022-now
- 1
United States 1.1k works
- 2
China 938 works
- 3
Japan 418 works
- 4
India 302 works
- 5
Italy 238 works
- 6
United Kingdom 217 works
- 7
Germany 205 works
- 8
Brazil 183 works
- 9
South Korea 177 works
- 10
Türkiye 164 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Bone health and treatments research?
By volume in 2022-now, Harvard University publishes the most Bone health and treatments research, followed by Shanghai Jiao Tong University and Sichuan University.
By volume, 2022-now
- 1
Harvard University
United States 46 works
- 2
Shanghai Jiao Tong University
China 29 works
- 3
Sichuan University
China 29 works
- 4
Peking University
China 27 works
- 5
All India Institute of Medical Sciences
India 27 works
- 6
Seoul National University
South Korea 22 works
- 7
Inserm
France 21 works
- 8
Zhejiang University
China 21 works
- 9
Mayo Clinic
United States 20 works
- 10
Yonsei University
South Korea 19 works
Who are the leading researchers in Bone health and treatments?
The most-cited researchers publishing on Bone health and treatments include Freddie Bray, George Davey Smith and Walter Churchill Willett.
- 1
Freddie Bray
France 550k citations
- 2
George Davey Smith
United Kingdom 435k citations
- 3
Walter Churchill Willett
United States 411k citations
- 4
Hermann Brenner
Germany 343k citations
- 5
Shizuo Akira
Japan 342k citations
- 6
Cyrus Cooper
United Kingdom 342k citations
- 7
Jun Wang
China 340k citations
- 8
Giuseppe Remuzzi
Italy 328k citations
- 9
John P. A. Ioannidis
United States 317k citations
- 10
Graeme J. Hankey
Australia 316k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Bone health and treatments research done?
The largest centres of Bone health and treatments research in 2022-now are Beijing (China), Tokyo (Japan), Seoul (South Korea) and Shanghai (China).
Where is the best place to study Bone health and treatments?
Among universities, judged by research, Harvard University, Zhejiang University and Soochow University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Bone health and treatments, country by countryIs Bone health and treatments research growing?
Output in 2022-2025 was 7% lower than in 2018-2021, peaking in 2013.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Bone health and treatments as a percentage of every work published that year, 0.024% in 2024.
Fractional works of Bone health and treatments over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Bone health and treatments. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.